Neopenda is a Chicago-based healthtech company tackling a critical challenge in global healthcare: the lack of reliable patient monitoring in low-resource hospitals.
Its flagship device, neoGuard, is a wearable vital signs monitor that enables a single nurse to track multiple patients simultaneously, measuring pulse rate, oxygen saturation, respiratory rate, and temperature in real time.
Designed for settings with limited electricity, internet, and staffing, neoGuard is CE-marked, ISO-certified, and already in use by ministries of health, NGOs, and hospital networks across East Africa.
Beyond the technology, Neopenda is building for long-term impact by shifting manufacturing to Africa and strengthening local healthcare capacity. Backed by more than $6 million from partners including Cisco, Vodafone, and WHO-affiliated organizations, the company is well positioned to scale across emerging markets.
We’re excited to announce that Realize Impact has invested in Neopenda. By expanding access to lifesaving healthcare technology where it’s needed most, Neopenda exemplifies the kind of mission-driven innovation we’re proud to support.
